Global Aminoglycosides Market Share

Statistics for the 2023 & 2024 Global Aminoglycosides market share, created by Mordor Intelligence™ Industry Reports. Global Aminoglycosides share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Antibiotics Research Aminoglycosides Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Aminoglycosides Industry

The aminoglycosides market is moderately fragmented and competitive. The market studied is composed of a large number of players and includes both small and large pharmaceutical manufacturers. Additionally, the increasing antibiotic resistance has prompted many early-stage biotechnology enterprises to enter this market. The expiry of patent exclusivity has led to large-scale generic manufacturing of aminoglycosides, particularly in the developing region of Asia-Pacific. The key market players include Cipla Limited, Pfizer Inc., AbbVie Inc. (Allergan PLC), Teva Pharmaceutical Industries Ltd, and Zoetis Inc., among others.

Aminoglycosides Market Leaders

  1. Pfizer Inc.

  2. AbbVie Inc (Allergan Plc)

  3. Teva Pharmaceutical Industries Ltd

  4. Zoetis Inc

  5. Cipla Limited

*Disclaimer: Major Players sorted in no particular order

AMino.png

Aminoglycosides Market Report Snapshots

Aminoglycosides Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)